Skip to main content
Call 662-222-0202
Home » What's New » Cutting Edge Glaucoma Technology

Cutting Edge Glaucoma Technology

Some 2.5 million North Americans struggle with glaucoma, a progressive eye disease that robs its sufferers of their vision, if unmanaged. Associated with high eye pressure and damage to the optic nerve, the main method of preventing blindness and low vision from glaucoma is by maintaining low levels of IOP (intraocular pressure). Unstable glaucoma may require frequent visits to an eye doctor for glaucoma monitoring to keep it under control.

In recent years a parallel disorder, high blood pressure, has become widely known for producing results that vary significantly, even from hour to hour. Both blood pressure and eye pressure can be affected by such a wide range of environmental and other factors – from the way you stand to the weather – that taking a single reading on a given day may not provide a good indication of patient health.

The need for more accurate diagnostic tools has prompted researchers at Stanford University and Bar Ilan University to collaborate in the development of a 24-hour a day IOP monitor for glaucoma patients. The device, which eye doctors hope will be available within a few years, is actually an eye implant!

It is so tiny, it’s designed to fit inside a standard intraocular lens – the kind used in cataract surgery – and, according to tests conducted by the U.S. Air Force, it will not distort vision.

The implanted glaucoma monitor is based on simple physics, using fluid levels in a tiny tube to precisely measure IOP. When available to the public, it may be paired with a custom smartphone app or wearable technology like Google glass to record eye pressure all the time, and the data can be shared with the patient’s ophthalmologist or optometrist.

Recent studies indicated that round-the-clock IOP monitoring would result in modified treatment for up to 80% of patients. Prevention of intraocular pressure spikes by measuring IOP throughout a 24 hour cycle would enable eye doctors to optimize a treatment plan. Since peripheral vision loss from optic nerve damage is not reversible, treatment is aimed at preventing vision loss from glaucoma. 

x

Valued Patients,

Here at Brooks Eye Center, our patients’ and staff’s health and safety is our utmost priority. Given the recent outbreak of COVID-19, we are closely monitoring the situation as it applies to our patients and staff and adjusting procedures accordingly. We want our patients to know that we will do everything within our scope to keep providing quality eyecare while being diligent about infection control and prevention.

Our exam areas are being cleaned and disinfected after each patient is treated and all our staff are following strict hand-washing and sanitizing regimens. We have also implemented a pre-screening process and are taking measures to minimize waiting in common areas.

In addition to our in-office efforts, please consider the following preventative measures: if you have traveled internationally, been on a cruise, or traveled to a high-risk area, please call our office before coming in. Also, if you have a compromised immune system, have experienced any respiratory symptoms (cough, shortness, or fever), please reschedule to been seen at a later date.

These procedures are an effort to minimize any unnecessary exposure to possible viruses and infections to our staff and patients, as well as to prevent the spread of this virus as much as you can. Your patience and understanding during this time is greatly appreciated. Please don’t hesitate to call our office with any questions or concerns.

Thank you!